D-0609-2026 Class II Ongoing

Recalled by The Harvard Drug Group LLC — Dublin, OH

FDA drug recall D-0609-2026 was initiated by The Harvard Drug Group LLC on Jun 16, 2026 and is designated Class II. Reason for recall: Subpotent Drug The recall status is ongoing. Affected quantity: 790 Cartons.

Recall details

Product Type
Drugs
Report Date
Jul 1, 2026
Initiation Date
Jun 16, 2026
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
790 Cartons.

Product description

Carton Label: MAJOR, Methylergonovine Maleate Tablets, USP, 0.2 mg, 20 TABLETS (2 x 10), Rx only, Packaged and Distributed by: MAJOR PHARMACEUTICALS, Indianapolis, in 46268, NDC 0904-7282-10. Blister Label: Methylergonovine Maleate Tablets, 0.2 mg, USP, One Tablet, Major Pharm/Indianapolis, IN 46268, NDC 0904-7282-10.

Reason for recall

Subpotent Drug

Distribution pattern

U.S. Nationwide.

Code information

Lots: N02327, expires: 09/2026; N02740, expires: 12/2026; N03069, expires: 08/2027.

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0609-2026
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0609-2026. Report a data issue: hello@regdatalab.com.